Cleavage fragments are small particles produced when a non-asbestiform mineral is crushed or broken along its natural planes of weakness. They can share the same chemistry as asbestos minerals and may look needle-like under a microscope, but they grew as blocky crystals rather than as true asbestos fibers. Distinguishing cleavage fragments from asbestos fibers is one of the central technical disputes in many asbestos cases.
Origin
The term comes from mineralogy, where "cleavage" (from Old English cleofan, to split) describes the tendency of a crystal to break along defined planes. The cleavage-fragment-versus-fiber debate emerged in the 1970s and 1980s as regulators, industry, and researchers argued over how OSHA, NIOSH, and EPA counting rules should treat elongated mineral particles from quarries, talc, taconite, and vermiculite.
Significance in Asbestos Context
For a patient, this term often appears when a defendant argues that the mineral particles found in a product, a workplace, or even the patient's own lung tissue were cleavage fragments, not asbestos, and therefore did not cause the disease. This defense is common in cases involving talc, taconite, industrial minerals, and certain vermiculite or amphibole-bearing ores. Whether a particle is a true asbestos fiber depends on its growth habit, aspect ratio, internal structure, and behavior, which require analytical methods such as polarized light microscopy (PLM), transmission electron microscopy (TEM), and selected area electron diffraction (SAED) performed by a qualified mineralogist. Much of the scientific and regulatory community, including the Helsinki Criteria and most public-health agencies, treats elongate amphibole particles as potentially hazardous regardless of whether they are called "asbestiform," and this dispute is actively contested in litigation.
Example Sentence
The defense expert testified that the particles in the talc were cleavage fragments rather than asbestos, but the plaintiff's mineralogist countered with electron microscopy showing true asbestiform tremolite fibers with characteristic bundles and splayed ends.
The Cleavage Fragment Controversy
Whether cleavage fragments should be counted and regulated as asbestos has been argued since the 1970s, when OSHA, MSHA and EPA wrote the rules defining a regulated fiber. Mining interests, particularly taconite and crushed-stone operators, pushed to exclude fragments of non-asbestiform amphiboles, and the dispute carried on through the Libby vermiculite litigation. Defendants often argue that amphibole particles found in a product or in lung tissue were "just cleavage fragments" and could not have caused disease; plaintiffs' experts respond that particles meeting the fiber dimensions (at least 5 µm long with an aspect ratio of at least 3:1), especially the longer and thinner ones, have been shown in animal and epidemiologic studies to cause mesothelioma and lung cancer. How a court resolves the question can decide whether a talc, vermiculite, taconite or quarry exposure counts as asbestos exposure at all.
Related Terms
Asbestiform, Amphibole, Tremolite, Aspect Ratio, Transmission Electron Microscopy (TEM), Non-Asbestiform
Notes
- If your case involves talc, taconite, vermiculite, or industrial mineral exposure, expect the defense to raise the cleavage-fragment argument; ask your legal team whether a qualified mineralogist has examined the product samples or tissue burden analysis.
- Preserve any product samples, original packaging, plant materials, or prior industrial hygiene reports. Re-analysis under TEM can be decisive in distinguishing fibers from fragments.
- Ask whether expert reports identify particles by growth habit (asbestiform vs. massive), not just by chemistry or aspect ratio alone; aspect ratio counting rules (e.g., 3:1 or 5:1) do not by themselves resolve the dispute.
- Be aware that some regulatory counting methods historically excluded cleavage fragments, which industry defendants may cite, but health-effects research increasingly shows that elongate amphibole particles can also cause disease.
In the research library
30 studies in our medical research library mention Cleavage Fragment in the title or abstract. Among the most cited:
- An evaluation of the risks of lung cancer and mesothelioma from exposure to amphibole cleavage fragmentsJ.F. Gamble, G.W. Gibbs, 2008 · Regulatory Toxicology and Pharmacology · cited 74 times
- Assessment of the pathogenic potential of asbestiform vs. nonasbestiform particulates (cleavage fragments) in in vitro (cell or organ culture) models and bioassaysB.T. Mossman, 2008 · Regulatory Toxicology and Pharmacology · cited 50 times
- Dimensions of elongated mineral particles: a study of more than 570 fibers from more than 90 cases with implications for pathogenicity and classification as asbestiform vs. cleavage fragmentsV.L. Roggli, C.L. Green, 2019 · Ultrastructural Pathology · cited 13 times
- An inter-laboratory study to determine the effectiveness of procedures for discriminating amphibole asbestos fibers from amphibole cleavage fragments in fiber counting by phase-contrast microscopyM. Harper, E.G. Lee, J.E. Slaven, et al, 2012 · The Annals of Occupational Hygiene · cited 13 times
- Surface charge heterogeneity in amphibole cleavage fragments and asbestos fibersJ.E. Schiller, S.L. Payne, S.E. Khalafalla, 1980 · Science · cited 13 times
The journals that publish most on it: Toxicology and Applied Pharmacology (4), Regulatory Toxicology and Pharmacology (3), The Annals of Occupational Hygiene (3).
Category: Fiber & Material Properties · All Lexicon terms A–Z
This page is provided for general informational purposes and does not constitute legal advice. Every asbestos case turns on its own facts, exposure history, diagnosis, deadlines, available evidence, and applicable law. Reviewing this page does not create an attorney-client relationship. For advice about your specific situation, call 833-4-ASBESTOS for a free case review.